Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Marker Therapeutics (MRKR) Other Operating Expenses (2018 - 2025)

Marker Therapeutics (MRKR) has disclosed Other Operating Expenses for 2 consecutive years, with $453135.0 as the latest value for Q1 2025.

  • Quarterly Other Operating Expenses changed N/A to $453135.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $453135.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $453135.0 for FY2025, N/A changed from the prior year.
  • Other Operating Expenses for Q1 2025 was $453135.0 at Marker Therapeutics, down from $116.0 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $453135.0 in Q1 2025, with the low at $453135.0 in Q1 2025.